Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
PTEN Phosphohydrolase | 14 | 2020 | 1115 | 0.820 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2015 | 1347 | 0.410 |
Why?
|
Tumor Suppressor Protein p53 | 8 | 2018 | 2924 | 0.360 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2016 | 2058 | 0.340 |
Why?
|
Neoplasm Proteins | 4 | 2021 | 3612 | 0.320 |
Why?
|
Leukemia, Promyelocytic, Acute | 2 | 2021 | 251 | 0.310 |
Why?
|
Prostatic Neoplasms | 11 | 2020 | 11345 | 0.310 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2021 | 5251 | 0.300 |
Why?
|
Proto-Oncogene Proteins c-akt | 7 | 2024 | 2448 | 0.290 |
Why?
|
Tumor Suppressor Proteins | 4 | 2019 | 2802 | 0.290 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2024 | 3583 | 0.290 |
Why?
|
Disease Models, Animal | 11 | 2020 | 18137 | 0.290 |
Why?
|
Mice | 41 | 2024 | 81209 | 0.270 |
Why?
|
Anilides | 2 | 2020 | 409 | 0.260 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2005 | 88 | 0.260 |
Why?
|
Antineoplastic Agents | 7 | 2024 | 13627 | 0.260 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 6 | 2024 | 5251 | 0.250 |
Why?
|
Cytochromes c | 1 | 2005 | 173 | 0.250 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2018 | 101 | 0.240 |
Why?
|
Cell Line, Tumor | 21 | 2024 | 16932 | 0.230 |
Why?
|
Pericytes | 2 | 2018 | 293 | 0.220 |
Why?
|
RNA, Ribosomal | 2 | 2019 | 226 | 0.220 |
Why?
|
Animals | 47 | 2024 | 167960 | 0.220 |
Why?
|
Indoles | 3 | 2019 | 1829 | 0.210 |
Why?
|
Pantothenic Acid | 1 | 2022 | 20 | 0.210 |
Why?
|
Nuclear Proteins | 6 | 2019 | 5795 | 0.210 |
Why?
|
Coenzyme A | 1 | 2022 | 40 | 0.200 |
Why?
|
Neoplasm Metastasis | 4 | 2018 | 4902 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2005 | 1408 | 0.200 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2021 | 8512 | 0.200 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2022 | 126 | 0.190 |
Why?
|
Computational Biology | 1 | 2013 | 3505 | 0.190 |
Why?
|
Nipples | 1 | 2023 | 221 | 0.190 |
Why?
|
Caspases | 1 | 2004 | 878 | 0.190 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 8055 | 0.190 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2021 | 1888 | 0.180 |
Why?
|
Androgen Receptor Antagonists | 1 | 2021 | 123 | 0.180 |
Why?
|
Sesquiterpenes | 1 | 2021 | 176 | 0.170 |
Why?
|
Lipogenesis | 2 | 2020 | 210 | 0.170 |
Why?
|
Glucose Transporter Type 3 | 1 | 2019 | 16 | 0.170 |
Why?
|
Lung Neoplasms | 6 | 2024 | 13262 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2021 | 2864 | 0.170 |
Why?
|
Trans-Activators | 1 | 2009 | 2860 | 0.160 |
Why?
|
Quinolines | 1 | 2024 | 759 | 0.160 |
Why?
|
Dyskeratosis Congenita | 1 | 2019 | 73 | 0.160 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2021 | 507 | 0.160 |
Why?
|
Mutation | 10 | 2021 | 29957 | 0.160 |
Why?
|
Thyroid Neoplasms | 3 | 2018 | 2332 | 0.150 |
Why?
|
Sterol Regulatory Element Binding Proteins | 1 | 2018 | 25 | 0.150 |
Why?
|
Cytoplasm | 3 | 2013 | 1516 | 0.150 |
Why?
|
Databases, Factual | 1 | 2013 | 8022 | 0.150 |
Why?
|
Organoids | 2 | 2021 | 729 | 0.150 |
Why?
|
Caveolin 1 | 1 | 2019 | 257 | 0.150 |
Why?
|
Protein Phosphatase 1 | 1 | 2018 | 134 | 0.140 |
Why?
|
Anticarcinogenic Agents | 1 | 2019 | 249 | 0.140 |
Why?
|
Lipoylation | 1 | 2018 | 88 | 0.140 |
Why?
|
Cell Proliferation | 10 | 2024 | 10442 | 0.140 |
Why?
|
Pyridines | 2 | 2020 | 2879 | 0.140 |
Why?
|
Growth and Development | 1 | 2016 | 47 | 0.140 |
Why?
|
Signal Transduction | 14 | 2022 | 23374 | 0.140 |
Why?
|
Molecular Targeted Therapy | 4 | 2021 | 2803 | 0.140 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2019 | 3610 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2019 | 415 | 0.140 |
Why?
|
Apoptosis | 5 | 2021 | 9497 | 0.140 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2016 | 42 | 0.130 |
Why?
|
DNA, Intergenic | 1 | 2016 | 105 | 0.130 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2018 | 2053 | 0.130 |
Why?
|
Cell Cycle Proteins | 2 | 2024 | 3448 | 0.130 |
Why?
|
Neoplasms | 5 | 2019 | 22075 | 0.130 |
Why?
|
Mice, Transgenic | 10 | 2021 | 9530 | 0.130 |
Why?
|
Tretinoin | 1 | 2019 | 519 | 0.130 |
Why?
|
Proteomics | 2 | 2024 | 3817 | 0.130 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 317 | 0.130 |
Why?
|
RNA-Binding Proteins | 2 | 2016 | 1894 | 0.130 |
Why?
|
Benzimidazoles | 1 | 2021 | 858 | 0.130 |
Why?
|
HMGB1 Protein | 1 | 2017 | 137 | 0.130 |
Why?
|
Fertility | 1 | 2020 | 773 | 0.130 |
Why?
|
Genetic Pleiotropy | 1 | 2016 | 181 | 0.130 |
Why?
|
Cholesterol | 1 | 2024 | 2924 | 0.120 |
Why?
|
Pyrazines | 1 | 2021 | 1199 | 0.120 |
Why?
|
RNA, Messenger | 5 | 2019 | 12762 | 0.120 |
Why?
|
Animal Husbandry | 1 | 2015 | 64 | 0.120 |
Why?
|
Chemokine CXCL12 | 1 | 2017 | 454 | 0.120 |
Why?
|
Receptors, Androgen | 1 | 2021 | 1077 | 0.120 |
Why?
|
Transcription Factors | 5 | 2021 | 12102 | 0.120 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2018 | 608 | 0.120 |
Why?
|
Hematopoiesis | 1 | 2004 | 2063 | 0.120 |
Why?
|
Phthalazines | 1 | 2017 | 382 | 0.120 |
Why?
|
Elafin | 1 | 2014 | 31 | 0.120 |
Why?
|
Mice, SCID | 4 | 2021 | 2627 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2018 | 2829 | 0.120 |
Why?
|
Multiprotein Complexes | 3 | 2016 | 1120 | 0.120 |
Why?
|
Hemangiopericytoma | 1 | 2014 | 71 | 0.120 |
Why?
|
Hematopoietic Stem Cells | 2 | 2019 | 3390 | 0.110 |
Why?
|
Epigenomics | 1 | 2019 | 936 | 0.110 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2022 | 436 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2019 | 995 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 4 | 2020 | 5640 | 0.110 |
Why?
|
RNA | 2 | 2021 | 2723 | 0.110 |
Why?
|
Public Sector | 1 | 2015 | 265 | 0.110 |
Why?
|
Mice, Knockout | 8 | 2021 | 14374 | 0.110 |
Why?
|
Genes, Neoplasm | 1 | 2015 | 370 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2020 | 1613 | 0.110 |
Why?
|
Pancreatic Neoplasms | 2 | 2021 | 5349 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1728 | 0.110 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 413 | 0.110 |
Why?
|
Drug Repositioning | 1 | 2015 | 232 | 0.110 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2019 | 929 | 0.110 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2021 | 1722 | 0.100 |
Why?
|
NF-kappa B | 1 | 2021 | 2486 | 0.100 |
Why?
|
Therapies, Investigational | 1 | 2013 | 112 | 0.100 |
Why?
|
Gallbladder Neoplasms | 1 | 2014 | 190 | 0.100 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2014 | 428 | 0.100 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2012 | 87 | 0.100 |
Why?
|
Private Sector | 1 | 2015 | 397 | 0.100 |
Why?
|
Enzyme Activation | 1 | 2018 | 3602 | 0.100 |
Why?
|
Muscles | 1 | 2016 | 1581 | 0.100 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2015 | 325 | 0.100 |
Why?
|
Humans | 50 | 2024 | 760613 | 0.100 |
Why?
|
Naphthyridines | 1 | 2012 | 141 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1842 | 0.090 |
Why?
|
DNA-Binding Proteins | 2 | 2019 | 9591 | 0.090 |
Why?
|
Epithelial Cells | 2 | 2021 | 3663 | 0.090 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1483 | 0.090 |
Why?
|
Histones | 1 | 2021 | 2582 | 0.090 |
Why?
|
Neutrophils | 2 | 2020 | 3767 | 0.090 |
Why?
|
Ribosomes | 1 | 2013 | 501 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 496 | 0.090 |
Why?
|
Lysosomes | 3 | 2021 | 920 | 0.090 |
Why?
|
Myeloid Cells | 2 | 2018 | 821 | 0.090 |
Why?
|
Breast Neoplasms | 4 | 2023 | 21029 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3332 | 0.080 |
Why?
|
Chromatin | 1 | 2021 | 2938 | 0.080 |
Why?
|
Nanoparticles | 1 | 2020 | 1943 | 0.080 |
Why?
|
Oncogene Proteins | 2 | 2016 | 719 | 0.080 |
Why?
|
HEK293 Cells | 4 | 2019 | 4263 | 0.080 |
Why?
|
Drug Synergism | 2 | 2024 | 1752 | 0.080 |
Why?
|
Interprofessional Relations | 1 | 2015 | 989 | 0.080 |
Why?
|
Purines | 1 | 2012 | 605 | 0.080 |
Why?
|
Oncogenes | 2 | 2021 | 1220 | 0.080 |
Why?
|
Immunotherapy | 2 | 2021 | 4642 | 0.080 |
Why?
|
Sarcoma | 1 | 2019 | 1786 | 0.080 |
Why?
|
Medical Informatics | 1 | 2015 | 733 | 0.070 |
Why?
|
Drug Approval | 1 | 2015 | 816 | 0.070 |
Why?
|
Regeneration | 1 | 2016 | 1506 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11902 | 0.070 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 3844 | 0.070 |
Why?
|
Drug Discovery | 1 | 2015 | 1057 | 0.070 |
Why?
|
DNA | 1 | 2021 | 7233 | 0.070 |
Why?
|
Piperazines | 1 | 2017 | 2525 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1173 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2013 | 1262 | 0.070 |
Why?
|
Mass Spectrometry | 3 | 2022 | 2192 | 0.070 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2009 | 645 | 0.060 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2005 | 71 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4571 | 0.060 |
Why?
|
Androgens | 1 | 2013 | 1291 | 0.060 |
Why?
|
Open Reading Frames | 2 | 2020 | 814 | 0.060 |
Why?
|
Gene Expression Profiling | 5 | 2021 | 9406 | 0.060 |
Why?
|
Models, Biological | 6 | 2018 | 9468 | 0.060 |
Why?
|
Genome, Human | 1 | 2018 | 4418 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2913 | 0.060 |
Why?
|
Two-Hybrid System Techniques | 1 | 2005 | 458 | 0.060 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2005 | 192 | 0.060 |
Why?
|
Mice, Nude | 2 | 2021 | 3607 | 0.060 |
Why?
|
Peptides | 1 | 2016 | 4354 | 0.060 |
Why?
|
bcl-2-Associated X Protein | 1 | 2005 | 282 | 0.060 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2024 | 56 | 0.060 |
Why?
|
Sulfonamides | 1 | 2014 | 1977 | 0.060 |
Why?
|
Mice, Inbred C57BL | 6 | 2019 | 22020 | 0.060 |
Why?
|
Gene Knockout Techniques | 2 | 2019 | 802 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2014 | 2049 | 0.060 |
Why?
|
Androgen Antagonists | 1 | 2013 | 1442 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 698 | 0.060 |
Why?
|
Ubiquitination | 2 | 2019 | 1008 | 0.060 |
Why?
|
Pyrimidines | 1 | 2016 | 3016 | 0.060 |
Why?
|
RNA, Neoplasm | 1 | 2006 | 748 | 0.060 |
Why?
|
Proteome | 1 | 2013 | 1855 | 0.050 |
Why?
|
Male | 21 | 2021 | 359718 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1837 | 0.050 |
Why?
|
Keratin-7 | 1 | 2023 | 55 | 0.050 |
Why?
|
Endosomes | 2 | 2016 | 519 | 0.050 |
Why?
|
Mitosis | 2 | 2024 | 1191 | 0.050 |
Why?
|
Proteins | 3 | 2018 | 6029 | 0.050 |
Why?
|
Jurkat Cells | 1 | 2004 | 736 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1693 | 0.050 |
Why?
|
Acetyl Coenzyme A | 1 | 2022 | 75 | 0.050 |
Why?
|
Protein Stability | 1 | 2024 | 566 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2020 | 6130 | 0.050 |
Why?
|
Phosphorylation | 2 | 2024 | 8311 | 0.050 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2021 | 17 | 0.050 |
Why?
|
Telomerase | 1 | 2006 | 747 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2009 | 1959 | 0.050 |
Why?
|
Gene Amplification | 2 | 2018 | 1085 | 0.050 |
Why?
|
Blotting, Western | 2 | 2009 | 5039 | 0.050 |
Why?
|
Gene Silencing | 3 | 2018 | 1512 | 0.050 |
Why?
|
RNA, Small Interfering | 2 | 2021 | 3442 | 0.050 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1741 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3527 | 0.050 |
Why?
|
Cell Cycle | 2 | 2024 | 2935 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 631 | 0.050 |
Why?
|
Gene Expression | 1 | 2013 | 7587 | 0.040 |
Why?
|
Mice, Inbred ICR | 1 | 2021 | 364 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 1135 | 0.040 |
Why?
|
RNA, Small Nucleolar | 1 | 2019 | 26 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1155 | 0.040 |
Why?
|
HeLa Cells | 1 | 2005 | 3105 | 0.040 |
Why?
|
Spermatogenesis | 1 | 2020 | 257 | 0.040 |
Why?
|
U937 Cells | 1 | 2019 | 262 | 0.040 |
Why?
|
Leukemia | 1 | 2007 | 1523 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2021 | 929 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3800 | 0.040 |
Why?
|
Proto-Oncogenes | 1 | 2019 | 320 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11713 | 0.040 |
Why?
|
COS Cells | 1 | 2020 | 1129 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 895 | 0.040 |
Why?
|
HL-60 Cells | 1 | 2018 | 363 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5697 | 0.040 |
Why?
|
RNA Interference | 1 | 2005 | 2846 | 0.040 |
Why?
|
Endocytosis | 1 | 2021 | 959 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2021 | 872 | 0.030 |
Why?
|
Methylation | 1 | 2019 | 1081 | 0.030 |
Why?
|
Cell Communication | 1 | 2024 | 1653 | 0.030 |
Why?
|
K562 Cells | 1 | 2018 | 640 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2021 | 1697 | 0.030 |
Why?
|
Cytarabine | 1 | 2018 | 696 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1135 | 0.030 |
Why?
|
RNA Splicing | 1 | 2021 | 915 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2022 | 1993 | 0.030 |
Why?
|
Benzylamines | 1 | 2017 | 248 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2008 | 1901 | 0.030 |
Why?
|
Heterocyclic Compounds | 1 | 2017 | 247 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 4938 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1895 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2021 | 944 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 3709 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 2017 | 480 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2005 | 4356 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2018 | 724 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2019 | 1091 | 0.030 |
Why?
|
Microtubules | 1 | 2020 | 1072 | 0.030 |
Why?
|
Polysaccharides | 1 | 2020 | 1016 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2019 | 983 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2018 | 680 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1229 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2022 | 1902 | 0.030 |
Why?
|
Heterozygote | 2 | 2011 | 2798 | 0.030 |
Why?
|
Protein Binding | 1 | 2005 | 9335 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 788 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 384 | 0.030 |
Why?
|
Exons | 1 | 2019 | 2389 | 0.030 |
Why?
|
Metabolomics | 1 | 2022 | 1628 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 4035 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2016 | 562 | 0.030 |
Why?
|
Valine | 1 | 2014 | 409 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3618 | 0.030 |
Why?
|
Gene Duplication | 1 | 2013 | 314 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 2016 | 833 | 0.030 |
Why?
|
Nanostructures | 1 | 2017 | 547 | 0.030 |
Why?
|
Organ Specificity | 1 | 2016 | 1954 | 0.020 |
Why?
|
Testosterone | 1 | 2023 | 2470 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 1088 | 0.020 |
Why?
|
Cell Membrane | 1 | 2021 | 3682 | 0.020 |
Why?
|
Phenylthiohydantoin | 1 | 2013 | 204 | 0.020 |
Why?
|
Genotype | 2 | 2018 | 12957 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2013 | 659 | 0.020 |
Why?
|
Transfection | 1 | 2019 | 5781 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3539 | 0.020 |
Why?
|
Orchiectomy | 1 | 2013 | 470 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2896 | 0.020 |
Why?
|
Amino Acids | 1 | 2016 | 1714 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2017 | 1147 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6544 | 0.020 |
Why?
|
Cell Line | 1 | 2004 | 15620 | 0.020 |
Why?
|
Genes, myc | 1 | 2011 | 395 | 0.020 |
Why?
|
Fatty Acids | 1 | 2018 | 1804 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2380 | 0.020 |
Why?
|
Alleles | 2 | 2013 | 6900 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2016 | 1006 | 0.020 |
Why?
|
Female | 8 | 2024 | 391246 | 0.020 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2010 | 124 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4122 | 0.020 |
Why?
|
Pheochromocytoma | 1 | 2011 | 328 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2009 | 436 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1617 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2014 | 1167 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4496 | 0.020 |
Why?
|
Cell Movement | 1 | 2020 | 5206 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10185 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1634 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2019 | 2869 | 0.020 |
Why?
|
Nitriles | 1 | 2013 | 956 | 0.020 |
Why?
|
Mammals | 1 | 2013 | 1131 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2013 | 18955 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 869 | 0.020 |
Why?
|
Adenovirus E1A Proteins | 1 | 2007 | 73 | 0.020 |
Why?
|
Benzamides | 1 | 2013 | 1369 | 0.020 |
Why?
|
Glucose | 1 | 2019 | 4350 | 0.020 |
Why?
|
Treatment Failure | 1 | 2013 | 2647 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 64981 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2014 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2010 | 1055 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1218 | 0.020 |
Why?
|
Homozygote | 1 | 2010 | 1788 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2017 | 3047 | 0.010 |
Why?
|
Zebrafish | 1 | 2016 | 2997 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4742 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2010 | 1674 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6316 | 0.010 |
Why?
|
Cell Separation | 1 | 2009 | 1720 | 0.010 |
Why?
|
Gene Deletion | 1 | 2011 | 2668 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 2011 | 1347 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5745 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2010 | 2104 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12444 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7593 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13451 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 2379 | 0.010 |
Why?
|
Lung | 1 | 2019 | 9994 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17624 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10181 | 0.010 |
Why?
|
DNA Damage | 1 | 2010 | 2442 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3442 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29661 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 935 | 0.010 |
Why?
|
Fibroblasts | 1 | 2010 | 4089 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5869 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5782 | 0.010 |
Why?
|
Myelodysplastic Syndromes | 1 | 2008 | 1401 | 0.010 |
Why?
|
Middle Aged | 2 | 2023 | 220359 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9278 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11481 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58980 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2006 | 2526 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11070 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 17790 | 0.000 |
Why?
|
Aged | 1 | 2020 | 169143 | 0.000 |
Why?
|
Adult | 1 | 2020 | 220007 | 0.000 |
Why?
|